Cambridge Healthtech Institute’s (CHI) flagship event, the Molecular Medicine Tri-Conference (February 24-27, 2009) will feature four of molecular medicine’s thought leaders as Plenary Keynotes.
Needham, MA (PRWEB) November 21, 2008 -— Cambridge Healthtech Institute’s (CHI) flagship event, the Molecular Medicine Tri-Conference (February 24-27, 2009) will feature four of molecular medicine’s thought leaders as Plenary Keynotes.
David Ewing Duncan, Chief Correspondent of NPR Talk’s “Biotech Nation” and best-selling Author of “Masterminds”, will offer his insights during his presentation “Brave New Age of Personalized Medicine”, scheduled Thursday, February 26, 2009 at 2:25pm.
Jay M. Tenenbaum, Ph.D, Chairman and Chief Scientist of CollabRx, Inc., will deliver a keynote presentation to discuss “Using Molecular Medicine to do Therapeutic Development in the Network Age”, on Wednesday, February 25, 2009 at 8:55am. Dr. Tenenbaum is a leader in internet commerce and tells the personal and timely story of transforming healthcare and accelerating therapy development through virtual biotechs.
Michael J. Yaszemski, M.D., Ph.D., Brigadier General of the United States Air Force Reserves and Professor of Orthopedic Surgery and Biomedical Engineering, College of Medicine, Mayo Clinic, is breaking new ground in spinal cord nerve regeneration. Dr. Yaszemski’s presentation, “Tissue Engineering Strategies for Musculoskeletal Regenerative Medicine in Civilian and Military Applications”, is on Thursday, February 26, 2009 at 7:30am.
James A. Wells, Ph.D., Professor and Chair of Pharmaceutical Chemistry, and Professor of Cellular & Molecular Pharmacology at the University of California, San Francisco is a pioneer in the hot area of fragment-based screening. Dr. Wells’ Keyno
Copyright©2008 Vocus, Inc.
All rights reserved